Back to top

basic-materials: Archive

Zacks Equity Research

PRM Prices $550 Million Senior Secured Notes to Fund Acquisition

PRM prices $550M of 6.250% senior secured notes due 2034, with proceeds and cash on hand set to fund the planned MMT acquisition.

Zacks Equity Research

BASF and OQEMA Ink Distribution Deal in Central and Eastern Europe

BASFY partners with OQEMA to expand distribution of polymer dispersions and additives across Central and Eastern Europe starting Jan. 1, 2026.

Anindya Barman

Barrick Mining vs. Agnico Eagle: Which Gold Miner Has More Glitter?

Gold prices are surging, and Barrick and Agnico Eagle are racing ahead with projects and cash flow gains while boosting investor returns.

Anindya Barman

3 Top Fertilizer Stocks That Your Portfolio Must Have for 2026

After a 2024 slump, fertilizer prices rebounded in 2025, lifting margins. NTR, YARIY and IPI face higher costs but solid demand into 2026.

Zacks Equity Research

Nucor Expects Q4 Earnings to Dip on Seasonality, Stays Bullish on 2026

NUE guides Q4 EPS at $1.65-$1.75, down sequentially on seasonality, but 2026 demand outlook stays upbeat.

Shaun Pruitt

2 Capital Efficient Stocks to Buy on the Dip: AEM, FIX

Most supportive of the notion that the incredible performances of these highly ranked stocks will eventually continue is their capital efficiency.

Madhurima Das

Nuclear Comeback in 2026? 3 Uranium Stocks to Power Your Portfolio

Nuclear energy's revival is lifting uranium demand, putting stocks like CCJ, UEC and LEU in focus as governments back reactors, fuel security and long-term capacity growth.

Sreeja Deb

Is AU Poised for Another Robust Y/Y Adjusted EBITDA Increase?

AngloGold Ashanti's adjusted EBITDA jumped 121% y/y in the first nine months of 2025, fueled by higher output, cost discipline and strong gold prices.

Zacks Equity Research

Agnico Eagle Acquires 26M Osisko Metals Shares, Boosts Stake

AEM boosts its stake in Osisko Metals with a C$12.48M private placement, lifting ownership to 9.85% and adding investor rights.

Zacks Equity Research

BASFY to Divest Optical Brightening Agent Business to Catexel

BASF SE agrees to sell its optical brightening agent business to Catexel, continuing its Winning Ways portfolio shift, with closing expected in Q1 2026.